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Background and purpose: To evaluate the current status of radiotherapy facilities, stafﬁng, and
equipment, treatment and patients in Poland for the years 2005–2011 following implemen-
tation of the National Cancer Programme.
Methods: A survey was sent to the radiotherapy centres in Poland to collect data on available
equipment, stafﬁng, and treatments in the years 2005–2011.
Results: In 2011, 76,000 patients were treated with radiotherapy at 32 centres vs. 63,000
patients at 23 centres in 2005. Number of patients increased by 21%. In 2011, there were
453  radiation oncologists – specialists (1 in 168 patients), 325 medical physicists (1 in 215
patients), and 883 radiotherapy technicians (1 in 86 patients) vs. 320, 188, and 652, respec-
tively, in 2005. The number of linear accelerators increased by 60%, from 70 units in 2005
to  112 in 2011. The current linac/patient ratio in Poland is 1 linac per 678 patients. Waiting
times from diagnosis to the start of treatment has decreased.
Conclusion: Compared to 2005, there are more treatment facilities, more  and better equip-ment  (linacs), and more cancer care specialists. There are still large differences between
the 16 Polish provinces in terms of equipment availability and ease of access to treatment.
However, radiotherapy services in Poland have improved dramatically since the year 2005.
©  2013 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All
increasing number of tumour locations and became highly.  Backgroundn recent years, major technological advances have improved
he effectiveness of radiotherapy. Radiotherapy has become
ver more  precise, making it possible to deliver highly targeted
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therapy that spares the normal healthy tissue surrounding
the tumour.1–3 As a result, radiotherapy is indicated in anie Memorial Institute, Garncarska 11, 31-115 Krakow, Poland.
complex.4–8 All of these factors, together with the rising
incidence of certain cancers, have increased demand for radio-
therapy services.7–12
ed by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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According to the ESTRO (European Society for Radiation
Oncology) and the OECI (Organization of European Cancer
Institutes), approximately 70% of patients who undergo cancer
treatment will receive radiotherapy (6). Delivery of radiothe-
rapy services to so many  patients obviously requires a large
investment in infrastructure and personnel and the ESTRO
recently published recommendations for appropriate levels of
radiotherapy infrastructure and stafﬁng.9
In the year 2011 approximately 76,000 patients under-
went radiotherapy in Poland.13 Due to expected increases in
demand, it is estimated that at least 100,000 patients per year
will require radiotherapy treatment in Poland in the coming
years. To assess the preparedness of Poland to meet this grow-
ing demand for radiotherapy services, we carried out a survey
of all radiotherapy treatment centres in Poland, requesting
data on infrastructure, stafﬁng, and treatments from 2005 to
2011.13–18 We  present the results here.
2.  Materials  and  methods
The National Consultant for Radiotherapy, sent detailed,
paper-based questionnaires to heads of departments of all
radiotherapy centres providing radiotherapy in 2005–2011.13–18
The national consultants are medical specialists nominated
by Scientiﬁc Societies and the Chamber of Physicians and for-
mally appointed by the Minister of Health to advise in various
aspects of health delivery in particular medical specialities. All
known radiotherapy centres, both public and private, located
in the 16 provinces (vovoidships) in Poland were surveyed. The
survey was sent to the all radiotherapy treatment centres in
Poland, all of which completed and returned the survey (100%
response rate).
The survey (see Appendix A – Tables 3–5) included
questions on personnel, equipment (external radiotherapy,
brachytherapy, simulators and treatment planning devices),
type of the centre, and number of patients treated. Respon-
dents were asked to provide data for years 2005–2011. All
centres were asked to report the number of radiation oncolo-
gists, medical physicists and radiotherapy technicians.
To make analysis of the data easier we provide map  of
Poland with all provinces shown (Fig. 1) and structure of the
Polish population in the years 2005–2010 (Fig. 2).19,20
2.1.  Statistical  analysis
In this descriptive study categorical variables were described
as percentages and continuous variables by means ± standard
error (SE). The Statistical Package for the Social Sciences, ver-
sion 13.0 (SPSS Inc., Chicago, Illinois, USA) was used to perform
the statistical analysis.
3.  Results
3.1.  Radiotherapy  facilitiesThe number of cancer care centres in Poland increased from
23 in 2005 to 32 in 2011. Table 1 shows all centres that perform
radiotherapy and the treatment methods (EBRT, BT, etc.) avail-
able at those centres. Almost all centres that offered externalFig. 1 – Provinces and province capital cities in Poland.
beam radiotherapy (EBRT) also provide brachytherapy. Some
centres also provided selective radiotherapy in cooperation
with the larger centres. Of the 32 centres that provide radio-
therapy, 3 are scientiﬁc research institutes, 5 are university
clinics specialising in radiotherapy, 8 are regional cancer cen-
tres, 10 are radiotherapy centres that are part of regional or
municipal hospitals, and 6 are private.
3.2.  Equipment
As shown in Fig. 3, from 2005 to 2011, the number of accelera-
tors increased by 60% (from 70 to 112 units) while installed
Cobalt-60 units decreased by 75% (from 12 to 3). Of the
70 accelerators in use in 2005, only 1 was for intraopera-
tive radiotherapy; by early 2012, there were 2 accelerators
for intra-operative radiotherapy and 1 CyberKnife accelerator
(particulars see Appendix A Table 3).Table 2 shows population per 1 MV units (accelera-
tors + cobalt units) for whole country. As the table clearly
shows, the population/megavoltage units ratio improved (i.e.,
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Table 1 – Methods used in oncology centres in Poland.
Province Total
population as
of 31.12.2010
City/center EBRT Brachyt-
herapy
Intraoper-
ative EBRT
accelera-
tor
Intraoper-
ative EBRT
X-ray
Gammaknife Cyberknife Cyclotron
protons +
brachytherapy
eye
I-125 –
seeds
POLAND 38,200,037
DOLNOS´LA˛SKIE 2,877,840
Wrocław DCO  
Wrocław WSS 
Wałbrzych MCO  
KUJAWSKO-
POMORSKIE
2,069,543 Bydgoszcz  
LUBELSKIE 2,151,895
Lublin COZL   
Lublin AM 
LUBUSKIE 1,011,024 Zielona Góra  
ŁÓDZKIE 2,534,357 Łódz´   
MAŁOPOLSKIE 3,310,094
Kraków COOK   
Kraków SU   
Kraków USD 
Tarnów  
MAZOWIECKIE 5,242,911
Warszawa CO  
Warszawa CR Allenort 
Wieliszew  
OPOLSKIE 1,028,585 Opole  
PODKARPACKIE 2,103,505
Rzeszów  
Brzozów  
PODLASKIE 1,188,329 Białystok  
POMORSKIE 2,240,319
Gdan´sk  
Gdynia  
S´LA˛SKIE 4,635,882
Bielsko-Biała  
Gliwice    
Cze˛stochowa  
Jastrze˛bie Zdrój 
Katowice  
S´WIE˛TOKRZYSKIE 1,266,014 Kielce  
WARMIN´SKO-
MAZURSKIE
1,427,241 Olsztyn  
WIELKOPOLSKIE 3,419,426
Poznan´ WCO   
Poznan´ MCO  
ZACHODNIOPOMORSKIE 1,693,072
Szczecin   
Koszalin  
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Fig. 2 – Structure of the Polish population in the years 2005–2010.19,20
nd CFig. 3 – Total number of accelerators a
declined from 471,127/megavoltage units to 338,053/mega-
voltage units) markedly over this period due to the large
investment in new accelerators (particulars see Appendix A
– Table 4).
Fig. 4 shows population per 1 MV  units (accelera-
tors + cobalt units) by province in Poland for the years
2005–2011.
Fig. 5 shows the number of megavoltage units (accelera-
tors + cobalt units) and related equipment in use from 2005 to
2011. Over this time period, many  existing accelerators were
upgraded and many  more  new machines were purchased.
Many of the new machines came fully equipped with multileaf
collimators (MLC), micro multileaf collimations (microMLC),
Table 2 – Population in Poland per 1 MV units (accelerators + cob
Population per 1 M
Years 2005 2007 200
POLAND 471,127 414,407 366,6obalt-60 units in the years 2005–2011.
intensity modulated radiation therapy (IMRT), electronic por-
tal imaging devices (EPID), Volumetric Modulated Arc Therapy
(VMAT), image-guided radiation therapy (IGRT), and respira-
tory gating. Cobalt units were replaced by linear accelerators:
in 2005 12 Cobalts were in operation and in 2011 only 3.
Linac indicates linear accelerator; MLC, multileaf col-
limator; EPID, electronic portal imaging devices; IGRT,
image-guided radiotherapy; and IMRT,  intensity-modulated
radiotherapy.
The number of simulators increased by only 11% (from 36
in 2005 to 40 in 2011). This increase was smaller than might
be expected due to (1) removal of old and worn simulators,
and (2) a tendency to replace standard, dedicated radiotherapy
alt units) in the years 2005–2011.
V units (accelerators + cobalt units)
9 2010 2011
91 343,850 338,053
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Fig. 4 – Comparison of the number of inhabitants per 1 MV  units (accelerators + cobalt units) in the provinces in years 2005,
2007, 2009, 2010 and 2011 (see map  in Fig. 1).
Fig. 5 – Number of linacs and related equipment in use from 2005 to 2011 (no data for year 2006).
Fig. 6 – Features of radiotherapy centres in Poland in simulators and CT scanners for select years from 2005 to 2011.
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Fig. 7 – Features of radiotherapy centres in Poland – brachytherapy devices in the years 2005–2011.
by almost 36% (from 652 to 883). Fig. 9 shows the num-
ber of radiation oncologists (specialists), medical physicistscomputed tomography (CT) simulators with virtual simula-
tion stations (CT-VSIM stations). In 2011, there were a total
of 27 CT scan stations equipped with virtual simulation in the
32 oncology centres. Fig. 6 shows the available equipment for
planning radiotherapy (simulators, CT scanners, and CT sim-
ulators) from 2005 to 2011. Note that no data is available on
virtual simulation for the years 2005 and 2007.
The brachytherapy equipment available from 2005 to 2011
is shown in Fig. 7. As this graphic illustrates, the num-
ber of high-dose rate (HDR) afterloaders more  than doubled
between the years 2005 and 2011 (from 16 to 37, an increase of
131%). Although low-dose rate/medium-dose rate (LDR/MDR)
machines were the most common equipment in 2005, by 2011
only 1 remained in service. The number of pulsed-dose rate
(PDR) machines increased slightly (from 5 to 6) (particulars see
Appendix A – Table 5).
Fig. 8 – Population per brachytherapy device Fig. 8 shows the population per brachytherapy device in
2011, by province. As is clear from the ﬁgure, the ratio varies
widely by province.
3.3.  Personnel  and  stafﬁng  levels
Between 2005 and 2011, the number of radiation oncologists
in Poland increased by more  than 40% (from 320 to 453), and
the number of medical residents specialising in Radiation
Oncology increased by 15% (from 149 to 171). The number
of medical physicists increased by over 70% (from 188 to
325), and the number of radiotherapy technologists increasedand radiotherapy technicians (RTTs) employed in radiotherapy
centres.
in 2011, by province (see map  in Fig. 1).
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Fig. 9 – Personnel in radiotherapy centres from 2005 to 2011.
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adiation oncology in radiotherapy centres during the years
005–2011 (specialists in radiation oncology and physicians in
raining).
.4.  Patients
s the number of linacs and brachytherapy equipment
ncreased, so too did the number of patients. From 2007 to
011, the number of treated patients increased from 63,000
o 76,000, a 21% increase in 5 years (Fig. 11, particulars see
ppendix A – Table 4).
ig. 10 – Radiation oncologists and physicians in trainee (residen
ears 2005–2011.Fig. 12 shows the number of treated patients, radiothe-
rapy method utilized for treatment (i.e., brachytherapy and/or
EBRT) by province for the years 2007–2011.
4.  Discussion
In 2011, Poland had a total of 325 medical physicists and
453 radiation oncologists (physicians specialists) who  treated
76,000 radiotherapy patients, a ratio of 1 medical physicist
per 234 patients and 1 radiation oncologist per 168 patients.
It should be noted that in the matter of staff situation
ts in radiotherapy) employed in oncology centres in the
166  reports of practical oncology and radiotherapy 1 8 ( 2 0 1 3 ) 159–172
in raFig. 11 – Number of patients treated by radiotherapy 
in Poland improved signiﬁcantly over last eight years and
reached the level that meets, ESTRO, QUARTS recommenda-
tions for stafﬁng (1 radiation oncologist per 200–250 patients,
and 1 physicist per 450–500 patients).8,9,12 However there is
some concern about these ﬁgures. Particularly the QUARTS
study referred to the level of radiotherapy before 2005. Since
that time complexity of all procedures has increased thus
more  staff is required.2,3,21–29 This is why ESTRO launched
new project on Health Economics in Radiation Oncology
(HERO).28 Medical physicists in Poland are still more  involved
in treatment planning than in West European countries,
Fig. 12 – Number of patients treated with radiotherapy in the pro
in Fig. 1).diotherapy centers in Poland in the years 2007–2011.
where dominantly these duties are carried by dosimetrists
or physics assistants.7,8,21 Moreover residency programme in
medical physics speciality has started in Poland only few
years ago and total number of physicists working in radio-
therapy does not portrait well stafﬁng level in this category, as
only small portion was able to pass the required certiﬁcation
up to date. In some of the cancer centres staff partici-
pate in undergraduate teaching and research, which reduces
time dedicate to clinical work.2,21,27,30 We have not revised
these factors for the current analysis and further study is
required.
vinces in years 2007, 2008, 2009, 2010 and 2011 (see map
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The current linac/patient ratio in Poland (1 linac per 678
atients) does not comply with the ESTRO recommendation of
 linac per 450 patients.8 In general, however, it is safe to say
hat radiotherapy services, facilities, and stafﬁng have made
ajor progress since the year 2005.25,26
The government of Poland has made a concerted effort in
ecent years to improve cancer care and prevention in order
o bring Poland in line with other European countries. To
his end, the National Cancer Programme (NCP) was approved
y the Polish parliament on July 1, 2005. The NCP is an
mbitious and well-ﬁnanced plan 3 billion zloty (approxi-
ately D715 million allocated for the years 2006–2015) and
ncompasses a multipronged approach to cancer prevention,
reatment, and awareness. One of the major thrusts of the NCP
nvolves signiﬁcant funding to equip and modernize radio-
herapy departments throughout the country. As the results
f our survey show, the additional investments made by the
CP have dramatically improved access to care in Poland and
uality of care. In fact, one of the biggest improvements is
till to come with the planned launch, in the year 2014, of
he National Centre for Hadron Therapy at the Institute of
uclear Physics in Cracow. This is an exciting and impor-
ant development, as hadron therapy has several advantages
hat promises to further improve treatment outcomes in some
umour localizations.23
.1.  Radiotherapy  equipment
he World Health Organization (WHO) recommends a
tandard of 250,000–300,000 inhabitants per linac.7,10,18
iewed in this way, the number of linacs in Poland is still
nsufﬁcient. The current ratio is 1 MV  linac per 338,053 inhabi-
ants. However, this is a major improvement from 2005, when
here were 471,127 inhabitants per linac. Under the NCP, a
otal of 60 linacs were purchased and installed between 2008
nd 2011 at public centres (8 linacs at private centres). Nev-
rtheless, the number of linacs in use actually increased by
nly 42 machines over this period due to decommissioning of
utdated machines, including Cobalt-60 therapy units (of
hich only 2 are still in use in Poland). Likewise, newer
echnologies, including the GammaKnife and CyberKnife,
ave been added. Currently, there are 112 linacs for a treat-
ent population of 76,000 patients (1 linac per 678 patients).
o meet the ESTRO QUARTS guidelines of 1 linac per 450
atients (for a patient population of 76,000, this implies 168
inacs), Poland would need a net increase (after account-
ng for decommissioned units) of at least 44 linacs. That
s, under these standards, there is a current shortfall of
6 linac units in Poland without taking into consideration
he expected increase in demand in the next few years.
n terms of equipment, Poland has made vast improve-
ents in a very short time, but more  will need to be
one in coming years. The demand for new radiotherapy
achines may exceed the current estimate, which is based
n the models of stafﬁng revised in 2005, so it is likely
hat introduction of new technologies will require more
taff and more  equipment to be dedicated to radiotherapy.
ortunately, NCP funding is scheduled to continue through
016 and we  will be able to continue modernising andtherapy 1 8 ( 2 0 1 3 ) 159–172 167
expanding radiotherapy facilities and equipment during this
period.
4.2.  Regional  differences
There are still large differences between the 16 provinces
in terms of equipment availability and ease of access to
treatment. For example, in terms of brachytherapy devices
per million population, some provinces have more  than 1.4
million inhabitants per device while others have as few as
400,000 inhabitants per device. The same is true for linacs. In
some provinces, the population to linac ratio is over 422,000:1
(Lodzkie and Podkarpackie provinces) and in one province the
ratio is 476,000:1 (Warminsko-Mazurskie). In contrast, in other
regions, such as Slaskie, Podlaskie, and Zachodniopomorskie,
this ratio does not exceed 258,000:1. The reasons for such
wide regional differences are the same as observed in most
countries: population density and wealth. Notwithstanding
these regional differences, access to advanced radiotherapy
has been improved since 2005 and will continue improving.
5.  Conclusion
As this survey shows, radiotherapy facilities in Poland have
been substantially improved and upgraded. Although there is
still a gap between Poland and western EU countries in many
health measures, including life expectancy, the gap is closing
quickly as Poland has invested heavily in improving health
care services. Nevertheless the National Cancer Programme
has to be continued after year 2015 as a support to regular
reimbursement for the radiotherapy procedures.
Compared to 2005, there are more  comprehensive centres
(32 vs. 23), more  equipment with improved technology, and
more  cancer care specialists. As a result, access to treatment
has improved markedly. Moreover, investment in advanced
technologies and techniques (IMRT, tomotherapy, and
SBRT-CyberKnife) now allows us to offer patients the most
effective treatments to improve outcomes. Finally, one impor-
tant, and perhaps underappreciated, improvement resulting
from the increase in available human and technological
resources is in waiting times from diagnosis to the start
of treatment has decreased. Waiting time is an important
indicator of quality, and this dramatic reduction conﬁrms
that radiotherapy services in Poland have improved dra-
matically in recent years. For both patients and cancer care
professionals, this is welcome news.
Continuous study is needed to estimate the required
number of therapeutic machines and staff, as the rapid devel-
opment in science and technology modiﬁes the techniques
used.
To our knowledge, this is the ﬁrst comprehensive study
of radiotherapy facilities and stafﬁng in Poland. A follow-up
study should be performed to identify changes in infrastruc-
ture, human resources, and treatments that are sure to occur
in the next few years.Conﬂict  of  interest
None declared.
d rad168  reports of practical oncology anFinancial  disclosure
None declared.
Table 3 – Number of megavoltage units (linacs + cobalt units) in
Province Population as
of 31.12.2010
Cities 
POLAND 38,200,037 
DOLNOS´LA˛SKIE 2,877,840
Wrocław 
Wałbrzych 
KUJAWSKO-POMORSKIE 2,069,543 Bydgoszcz 
LUBELSKIE 2,151,895 Lublin 
LUBUSKIE 1,011,024 Zielona Góra 
ŁÓDZKIE 2,534,357 Łódz´ 
MAŁOPOLSKIE 3,310,094
Kraków COOK
Kraków SU 
Kraków USD 
Tarnów 
MAZOWIECKIE 5,242,911
Warszawa CO 
Wieliszew 
Warszawa Allenort
OPOLSKIE 1,028,585 Opole 
PODKARPACKIE 2,103,505
Rzeszów 
Brzozów 
PODLASKIE 1,188,329 Białystok 
POMORSKIE 2,240,319
Gdan´sk 
Gdynia 
S´LA˛SKIE 4,635,882
Bielsko-Biała 
Gliwice 
Katowice 
Cze˛stochowa
S´WIE˛TOKRZYSKIE 1,266,014 Kielce 
WARMIN´SKO-MAZURSKIE 1,427,241 Olsztyn 
WIELKOPOLSKIE 3,419,426
Poznan´ WCO 
Poznan´ MCO 
ZACHODNIOPOMORSKIE 1,693,072
Szczecin 
Koszalin 
a LINACS used only for intra-operative radiotherapy (the calculation not in
Table 4 – Number of population for 1 MV units (linacs + cobalt u
Province City/center 
2005 
POLAND 471,127 
DOLNOS´LA˛SKIE
Wrocław
578,089
Wałbrzych
KUJAWSKO-POMORSKIE Bydgoszcz 516,927 
LUBELSKIE Lublin 545,547 iotherapy 1 8 ( 2 0 1 3 ) 159–172Appendix  A
See Tables 3–6.
 radiotherapy centers in the years 2005–2011.
LINACS/Cobalt-60 units
2005 2007 2008 2009 2010 2011
70/12 85/8 95/7 99/5 106/5 112/3
5 7 6 6 6 6
– – 2 2 2 2
3/1 5/1 5 5 6 7
3/1 4 5 5 6 6
1/1 2/1 2/1 2/1 2/1 3
4/1 6 6 5 6 6
4 4 4 4 4 4
1a 1a 1a 1a 1a 1a
1 1 1 2 2 2
– 1 2 2 2 3
10/1 11 11 11 12 11
– – – 2 2 2
 – – – – – 0/1
2/1 2/1 2/1 2/1 2/1 2/1
1/1 1/1 2/1 2 2 2
1/1 1/1 2/1 3 3 3
3/1 4/1 4/1 3/1 4/1 4/1
3 3 3 3 3 3
3 4 4 3 3 3
2 2 2 3 3 3
7 8 9 9 10 11
2 2 2 2 2 2
1 1 1 2 2 2
3/1 4 4 4 4 4
2 3 3 3 3 3
4/1 4/1 5/1 6/1 7/1 7
– – 1a 1a 1a 1a
– – 2 2 2 2
4/1 4/1 4/1 4/1 4/1 5
– – – – – 2
cluded the population for 1 MV units).
nits) in the years 2005, 2007, 2009, 2010, 2011.
Population per 1 MV units
2007 2009 2010 2011
414,407 366,691 343,850 338,053
411,760 359,632 359,578 359,730
344,395 413,584 344,847 295,649
543,192 432,366 359,534 358,649
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Table 4 (Continued)
Province City/center Population per 1 MV units
2005 2007 2009 2010 2011
LUBUSKIE Zielona Góra 504,596 336,173 336,321 336,682 337,008
ŁÓDZKIE Łódz´ 516,427 427,700 509,772 423,639 422,393
MAŁOPOLSKIE
Kraków COOK
652,588 545,201 410,892 412,284 367,788
Kraków SU
Kraków USD
Tarnów
MAZOWIECKIE
Warszawa CO
468,203 470,155 400,346 373,012 374,494Warszawa CR Allenort
Wieliszew
OPOLSKIE Opole 349,847 347,314 344,347 343,699 342,862
PODKARPACKIE
Rzeszów
524,449 524,391 419,899 420,346 420,701
Brzozów
PODLASKIE Białystok 300,250 239,220 297,868 237,946 237,666
POMORSKIE
Gdan´sk
366,167 314,799 369,919 371,683 373,387
Gdynia
S´LA˛SKIE
Bielsko-Biała
391,121 359,164 290,354 272,984 257,549
Gliwice
Katowice
Cze˛stochowa
S´WIE˛TOKRZYSKIE Kielce 321,596 319,960 318,196 317,530 316,504
WARMIN´SKO-MAZURSKIE Olsztyn 714,240 475,628 475,691 475,706 475,747
WIELKOPOLSKIE
Poznan´ WCO
672,505 675,700 377,513 340,828 379,936
Poznan´ MCO
ZACHODNIO- Szczecin
338,856 338,568 338,591 338,640 241,867POMORSKIE Koszalin
170
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Table 5 – Features of radiotherapy centers in the brachytherapy devices in the years 2005–2011.
Provinces Total
popula-
tion as of
31.12.2010
City/center Total number of BT devices Population/BT
device in
20112005 2007 2008 2009 2010 2011
Poland 38,200,037
42 devices, 21
LDR/MDR, 16 HDR, 5
PDR
45 devices, 18
LDR/MDR, 21 HDR, 6
PDR
41 devices, 8
LDR/MDR, 27 HDR, 6
PDR
42 devices, 5
LDR/MDR, 31 HDR, 6
PDR
42 devices, 1
LDR/MDR, 35 HDR, 6
PDR
44 devices, 1
LDR/MDR, 37 HDR, 6
PDR
868,183
LDR/MDR  HDR PDR LDR/MDR HDR PDR LDR/MDR HDR PDR LDR/MDR HDR PDR LDR/MDR HDR PDR LDR/MDR HDR PDR
DOLNOS´LA˛SKIE 2,877,840
Wrocław  DCO 1 1 1 1 1 1
1,438,920Wrocław  SPSK 1 1 1
Wałbrzych  MCO 1 1 1 1
KUJAWSKO-POMORSKIE 2,069,543 Bydgoszcz 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1,034,772
LUBELSKIE  2,151,895 Lublin 1 1 1 1 1 2 2 1,075,948
LUBUSKIE  1,011,024 Zielona Góra 1 1 1 1 1 1 1,011,024
ŁÓDZKIE  2,534,357 Łódz´ 2 1 2 1 1 2 2 2 1,267,179
MAŁOPOLSKIE 3,310,094
Kraków  COOK 1 1 1 1 1 2 1 2 2 1 2 1 2 1
662,019Kraków  SU Gin. 1 1 1
Tarnów  1 1 1
MAZOWIECKIE 5,242,911
Warszawa  2 2 3 1 3 1 3 1 3 1 3 1
1,048,582
Wieliszew  1 1 1
OPOLSKIE  1,028,585 Opole 2 1 2 1 1 1 1 1 1,028,585
PODKARPACKIE 2,103,505
Rzeszów  2 2 2 2 1 1
525,876
Brzozów  1 1 1 1 2 1 2 1
PODLASKIE  1,188,329 Białystok 1 1 1 1 1 1 1,188,329
POMORSKIE 2,240,319
Gdan´sk  1 1 1 1 1 1 1 2 1 1
1,120,160
Gdynia 1  1 1 1 1 1
S´LA˛SKIE 4,635,882
Bielsko-Biała  1 1 1 1
772,647
Gliwice  2 1 2 2 2 3 3
Katowice  1 1 1 1 1 1
Cze˛stochowa  1 1 1 1 1 1
S´WIE˛TOKRZYSKIE  1,266,014 Kielce 1 1 1 2 1 2 1 2 1 2 1 2 422,005
WARMIN´SKO-MAZURSKIE  1,427,241 Olsztyn 1 1 1 1 1 1 1 1 1,427,241
WIELKOPOLSKIE 3,419,426
Poznan´  WCO 2 1 1 2 1 1 2 2 1 2 1 2 1 2 1
683,885Poznan´  MCO 1 1 1 2
Poznan´  PSK UM 1 1
ZACHODNIOPOMORSKIE 1,693,072
Szczecin  2 1 2 1 1 1 1 1
846,536
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Table 6 – Number of patients treated with radiotherapy in provinces in 2007–2011.
Province Population as
of 31.12.2010
City Number of patients treated
2007 2008 2009 2010 2011
Poland 38,200,037 63,452 67,260 69,463 73,566 75,879
DOLNOS´LA˛SKIE 2,877,840
Wrocław 3801 3931 3782 3616 3736
Wrocław SPSK 17 – – – –
Wrocław WSS – – – – 10
Wałbrzych – 32 865 1277 1435
KUJAWSKO-POMORSKIE 2,069,543 Bydgoszcz 4228 4489 4638 5086 5156
LUBELSKIE 2,151,895
Lublin 2674 2586 2887 3309 3444
Lublin UM 54 43 34 40 16
LUBUSKIE 1,011,024 Zielona Góra 932 1291 1289 1177 1265
ŁÓDZKIE 2,534,357 Łódz´  2728 3072 3071 3199 3314
MAŁOPOLSKIE 3,310,094
Kraków COOK 2602 2821 2532 2852 2544
Kraków SU 211 189 315 336 374
Kraków USD 321 286 325 384 477
Tarnów – 316 813 1107 1325
MAZOWIECKIE 5,242,911
Warszawa 9423 9911 10,198 9287 9177
Wieliszew – – – 469 1392
Warszawa Allenort – – – – 243
OPOLSKIE 1,028,585 Opole 1021 1022 989 1157 1206
PODKARPACKIE 2,103,505
Rzeszów 1409 1303 1798 1361 1154
Brzozów 1892 2057 1853 1830 2258
PODLASKIE 1,188,329 Białystok 1833 1947 2025 1893 2064
POMORSKIE 2,240,319
Gdan´sk 1695 1750 1748 1949 2198
Gdynia 1290 1441 1382 1699 1488
S´LA˛SKIE 4,635,882
Bielsko-Biała 1224 1320 1415 1558 1594
Cze˛stochowa 1113 1662 1728 1959 1879
Gliwice 7020 7381 7104 8137 8036
Jastrze˛bie Zdrój – – – 14 31
Katowice 2275 2418 2085 2532 2489
S´WIE˛TOKRZYSKIE 1,266,014 Kielce 3170 2557 2900 3268 3368
WARMIN´SKO-MAZURSKIE 1,427,241 Olsztyn 1806 2132 2353 2236 2219
WIELKOPOLSKIE 3,419,426
Poznan´ WCO 7003 7528 6929 6371 5709
Poznan´ PSK UM 110 88 – – –
Poznan´ MCO – – 693 1651 1964
r
1ZACHODNIOPOMORSKIE 1,693,072
Szczecin 
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